W2O, an independent network of analytics, marketing and communications companies, has named Rita Glaze as its new practice leader of value, pricing and market access, it was reported yesterday.
In the new role, Glaze will strengthen the group's healthcare commercialisation offering and together with the practice's founder, Brian Reid, she will build a multi-dimensional team to help clients with pricing and reimbursement strategy and communications.
Glaze has 25 years' experience in the biopharmaceutical and life science sector with expertise in marketing, managed markets, pricing strategy and communications. She has held senior positions with organisations such as Takeda, Allscripts and Searle/Pharmacia. Earlier, she has led the network's design and implementation of its US market access communications offering.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer